Items where Author is "Tetard, David"

Article

Abdelaal, Gina, Carter, Andrew, Panagiotidis, Mihalis, Tetard, David and Veuger, Stephany (2022) Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines. Frontiers in Molecular Biosciences, 9. p. 1005092. ISSN 2296-889X

Bergin, Joseph C.J., Tan, Kean Kan, Nelson, Anya K., Amarandei, Cristina-Andreea, Hubscher-Bruder, Veronique, Brandel, Jeremy, Voinarovska, Varvara, Dejaegere, Annick, Stote, Roland H. and Tetard, David (2022) 1-Hydroxy-2(1H)-pyridinone-Based Chelators with Potential Catechol O-Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson’s Disease. Molecules, 27 (9). p. 2816. ISSN 1420-3049

Lewis, Frank, Bird, Kathleen, Navarro, Jean-Philippe, El Fallah, Rawa, Brandel, Jeremy, Hubscher-Bruder, Veronique, Tsatsanis, Andrew, Duce, James A., Tetard, David, Bourne, Samuel, Maina, Mahmoud and Pienaar, Ilse S. (2022) Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease. Dalton Transactions, 51 (9). pp. 3590-3603. ISSN 1477-9226

Kyriakou, Sotiris, Cheung, William, Mantso, Theodora, Mitsiogianni, Melina, Anestopoulos, Ioannis, Veuger, Stephany, Trafalis, Dimitris T., Franco, Rodrigo, Pappa, Aglaia, Tetard, David and Panayiotidis, Mihalis (2021) A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma. Investigational New Drugs, 39 (4). pp. 971-986. ISSN 0167-6997

Gutbier, Simon, Kyriakou, Sotiris, Schildknecht, Stefan, Ückert, Anna-Katharina, Brüll, Markus, Lewis, Frank, Dickens, David, Pearson, Liam, Elson, Joanna L., Michel, Sylvia, Hubscher-Bruder, Véronique, Brandel, Jeremy, Tetard, David, Leist, Marcel and Pienaar, Ilse (2020) Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants. Archives of Toxicology, 94 (9). pp. 3105-3123. ISSN 0340-5761

Kyriakou, Sotiris, Mitsiogianni, Melina, Mantso, Theodora, Cheung, William, Todryk, Stephen, Veuger, Stephany, Pappa, Algaia, Tetard, David and Panagiotidis, Mihalis (2020) Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma. Investigational New Drugs, 38 (3). pp. 621-633. ISSN 0167-6997

Workman, David G., Hunter, Michael, Wang, Shuning, Brandel, Jérémy, Hubscher, Véronique, Dover, Lynn and Tetard, David (2020) The influence of linkages between 1-Hydroxy-2(1H)-pyridinone Coordinating Groups and a Tris(2-aminoethyl)amine core in a novel series of synthetic Hexadentate Iron(III) Chelators on antimicrobial activity. Bioorganic Chemistry, 95. p. 103465. ISSN 0045-2068

Workman, David, Hunter, Michael, Dover, Lynn and Tetard, David (2016) Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents. Journal of Inorganic Biochemistry, 160. pp. 49-58. ISSN 0162-0134

Workman, David, Tsatsanis, Andrew, Lewis, Frank, Boyle, John, Mousadoust, Maryam, Hettiarachchi, Nishani, Hunter, Michael, Peers, Chris, Tetard, David and Duce, James (2015) Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators. Metallomics : Integrated Biometal Science, 7 (5). pp. 867-876. ISSN 1756-591X

Robinson-Miller, Adam, Wyatt, Mark and Tetard, David (2015) Epoxidation of Strained Alkenes Catalysed by (1,2-dimethyl-4(1H)pyridinone-3-olate)2MnIIICl. Journal of Molecular Catalysis A: Chemical, 398. pp. 376-390. ISSN 1381-1169

Book Section

Lewis, Frank and Tetard, David (2017) An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases. In: Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics. Elsevier, San Diego, pp. 399-414. ISBN 978-0-12-804562-6

Patent

Northumbria University, Tetard, David, Lewis, Frank (2016) Metal chelating compounds for use in treating diseases. WO2016079502A1.